New lung cancer drug improves survival by 14%

June 1, 2014 5:53 AM

12
0

New lung cancer drug improves survival by 14% and delays the growth of the cancer in many patients.

There seems to be a new hope for advanced lung cancer patients. A latest study that is yet to be published in any leading journal says that investigational targeted agent along with second-line chemotherapy improved the survival chances for patients for longer periods.